Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury

Eur J Pharmacol. 2015 Mar 5:750:32-8. doi: 10.1016/j.ejphar.2015.01.023. Epub 2015 Jan 23.

Abstract

Acanthoic acid, a pimaradiene diterpene isolated from Acanthopanax koreanum, has been reported to have anti-inflammatory activities. However, the effects of acanthoic acid on LPS-induced acute lung injury have not been reported. The purpose of this study was to investigate the protective effect of acanthoic acid on LPS-induced ALI and to clarify the possible anti-inflammatory mechanisms. In vivo, an LPS-induced ALI model in mice was used to assess the protective effects of acanthoic acid on ALI. Meanwhile, mouse alveolar macrophages MH-S were stimulated with LPS in the presence or absence of acanthoic acid. The expressions of TNF-α, IL-6 and IL-1β were measured by ELISA. LXRα and NF-κB expression were detected by Western blot analysis. The results showed that acanthoic acid downregulated LPS-induced TNF-α, IL-6 and IL-1β production in BALF. MPO activity and lung wet-to-dry ratio were also inhibited by acanthoic acid. In addition, acanthoic acid attenuated lung histopathologic changes. In vitro, acanthoic acid inhibited inflammatory cytokines TNF-α, IL-6 and IL-1β production and NF-κB activation in LPS-stimulated alveolar macrophages. Acanthoic acid was found to up-regulated the expression of LXRα. The inhibition of acanthoic acid on LPS-induced cytokines and NF-κB activation can be abolished by LXRα siRNA. In conclusion, our results suggested that the protective effect of acanthoic acid on LPS-induced ALI was due to its ability to activate LXRα, thereby inhibiting LPS-induced inflammatory response.

Keywords: Acanthoic acid; Acute lung injury; LPS; LXRα; NF-κB.

MeSH terms

  • Acute Lung Injury / complications
  • Acute Lung Injury / drug therapy*
  • Acute Lung Injury / metabolism
  • Acute Lung Injury / pathology
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Bronchoalveolar Lavage Fluid
  • Diterpenes / pharmacology*
  • Diterpenes / therapeutic use
  • Edema / complications
  • Interleukin-1beta / biosynthesis
  • Interleukin-6 / biosynthesis
  • Lipopolysaccharides / adverse effects*
  • Liver X Receptors
  • Lung / drug effects
  • Lung / metabolism
  • Lung / pathology
  • Macrophages, Alveolar / drug effects
  • Macrophages, Alveolar / metabolism
  • Male
  • Mice
  • Mice, Inbred BALB C
  • NF-kappa B / metabolism
  • Orphan Nuclear Receptors / metabolism
  • Peroxidase / metabolism
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Anti-Inflammatory Agents
  • Diterpenes
  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharides
  • Liver X Receptors
  • NF-kappa B
  • Nr1h3 protein, mouse
  • Orphan Nuclear Receptors
  • Tumor Necrosis Factor-alpha
  • acanthoic acid
  • Peroxidase